Announcements Trials
Browse Landscape

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 105Observational 4

Sponsor

Cancer Type

Dermatologic 4

Conditions

Breast Neoplasms 112Neoplasms 73Carcinoma, Non-Small-Cell Lung 36Carcinoma, Renal Cell 35Prostatic Neoplasms 34Colorectal Neoplasms 34Lung Neoplasms 31Melanoma 17Multiple Myeloma 15Ovarian Neoplasms 13Urinary Bladder Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasm Metastasis 11Lymphoma, Follicular 11Colonic Neoplasms 11Stomach Neoplasms 10Lymphoma 10Kidney Neoplasms 10Hematologic Neoplasms 10Rectal Neoplasms 9Arthritis, Rheumatoid 9Recurrence 8Papillomavirus Infections 8Leukemia, Myeloid, Acute 8Carcinoma, Hepatocellular 8Pancreatic Neoplasms 7Neoplasms, Plasma Cell 7Lymphoma, Large B-Cell, Diffuse 7COVID-19 7Leukemia, Lymphocytic, Chronic, B-Cell 6

Interventions

tirbanibulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Has results × Keratosis, Actinic × Clear all
NCT04969419 2025-01-14

Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo

Momentum Data

Completed
75,771 enrolled 19 charts
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Melanoma, Vitiligo, Keratosis, Actinic

NCT05260073 2024-09-20

PROAK

Almirall, S.A.

Completed
300 enrolled 9 charts
Dermatologic

Keratosis, Actinic

NCT01806961 2016-08-03

Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.

Spirig Pharma Ltd.

Terminated
16 enrolled 4 charts
Dermatologic

Keratosis, Actinic

NCT00668733 2010-07-20

Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year

Graceway Pharmaceuticals, LLC

Completed
179 enrolled 6 charts
Dermatologic

Skin Diseases, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡